CALLIDITAS THERAPEUTICS earnings per share and revenue

LC8 earnings per share for the last quarter are -0.03 EUR whereas the estimation was -0.08 EUR which accounts for 64.00% surprise. Company revenue for the same period amounts to 40.38 M EUR despite the estimated figure of 32.23 M EUR. Estimated earnings per share for the next quarter are -0.07 EUR, and revenue is expected to reach 33.07 M EUR. Also watch annual changes over time to get a bigger picture of LC8 earnings per share and revenue dynamics.